1. Home
  2. MLYS vs HTB Comparison

MLYS vs HTB Comparison

Compare MLYS & HTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • HTB
  • Stock Information
  • Founded
  • MLYS 2019
  • HTB 1926
  • Country
  • MLYS United States
  • HTB United States
  • Employees
  • MLYS N/A
  • HTB N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • HTB
  • Sector
  • MLYS Health Care
  • HTB
  • Exchange
  • MLYS Nasdaq
  • HTB NYSE
  • Market Cap
  • MLYS 893.0M
  • HTB 597.7M
  • IPO Year
  • MLYS 2023
  • HTB N/A
  • Fundamental
  • Price
  • MLYS $15.61
  • HTB $35.57
  • Analyst Decision
  • MLYS Strong Buy
  • HTB Buy
  • Analyst Count
  • MLYS 3
  • HTB 1
  • Target Price
  • MLYS $33.00
  • HTB $43.00
  • AVG Volume (30 Days)
  • MLYS 679.3K
  • HTB 38.1K
  • Earning Date
  • MLYS 05-12-2025
  • HTB 04-24-2025
  • Dividend Yield
  • MLYS N/A
  • HTB 0.68%
  • EPS Growth
  • MLYS N/A
  • HTB N/A
  • EPS
  • MLYS N/A
  • HTB 3.21
  • Revenue
  • MLYS N/A
  • HTB $190,527,000.00
  • Revenue This Year
  • MLYS N/A
  • HTB $5.93
  • Revenue Next Year
  • MLYS N/A
  • HTB $4.06
  • P/E Ratio
  • MLYS N/A
  • HTB $10.92
  • Revenue Growth
  • MLYS N/A
  • HTB N/A
  • 52 Week Low
  • MLYS $8.24
  • HTB $26.93
  • 52 Week High
  • MLYS $18.38
  • HTB $38.99
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 60.58
  • HTB N/A
  • Support Level
  • MLYS $14.03
  • HTB N/A
  • Resistance Level
  • MLYS $15.79
  • HTB N/A
  • Average True Range (ATR)
  • MLYS 0.95
  • HTB 0.00
  • MACD
  • MLYS 0.15
  • HTB 0.00
  • Stochastic Oscillator
  • MLYS 94.04
  • HTB 0.00

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About HTB HOMETRUST BANCSHARES INC

HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products. Company's principal business consists of attracting deposits from the general public and investing those funds, along with borrowed funds, in commercial real estate loans, construction and development loans, commercial and industrial loans, equipment finance leases, municipal leases, loans secured by first and second mortgages on one-to-four family residences including home equity loans and other consumer loans.

Share on Social Networks: